Lataa...
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
The introduction of biological therapies into clinical practice has dramatically modified the natural history of chronic inflammatory diseases, such as rheumatoid arthritis (RA). RA is a systemic autoimmune disease that causes articular damage and has a great negative impact on patients’ quality of...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5245809/ https://ncbi.nlm.nih.gov/pubmed/28144129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S104233 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|